BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1687064)

  • 1. Differential antibody responsiveness to p19 gag results in serological discrimination between human T lymphotropic virus type I and type II.
    Lal RB; Brodine SK; Coligan JE; Roberts CR
    J Med Virol; 1991 Dec; 35(4):232-6. PubMed ID: 1687064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.
    Mahieux R; Horal P; Mauclère P; Mercereau-Puijalon O; Guillotte M; Meertens L; Murphy E; Gessain A
    J Clin Microbiol; 2000 Nov; 38(11):4049-57. PubMed ID: 11060067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-I and HTLV-II.
    Lal RB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S170-8. PubMed ID: 8797720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-I and HTLV-II world-wide distribution: reanalysis of 4,832 immunoblot results.
    Madeleine MM; Wiktor SZ; Goedert JJ; Manns A; Levine PH; Biggar RJ; Blattner WA
    Int J Cancer; 1993 May; 54(2):255-60. PubMed ID: 8486428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.
    Horal P; Hall WW; Svennerholm B; Lycke J; Jeansson S; Rymo L; Kaplan MH; Vahlne A
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5754-8. PubMed ID: 1712105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein.
    Sato A; Isaka Y; Morita F; Ishii A; Goto Y; Imai J; Igarashi H; Yoshie O; Hinuma Y
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2969-73. PubMed ID: 1279104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral responses to the immunodominant gag and env epitopes of human T-lymphotropic virus type I among Melanesians.
    Lal RB; Rudolph DL; Nerurkar VR; Yanagihara R
    Viral Immunol; 1992; 5(4):265-72. PubMed ID: 1282011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
    Bonis J; Baillou A; Barin F; Verdier M; Janvier B; Denis F
    J Clin Microbiol; 1993 Jun; 31(6):1481-5. PubMed ID: 8314990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein.
    Palker TJ; Singer KH; Vahlne A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):10-9. PubMed ID: 8528727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of HTLV-I and HTLV-II infection in Africans using type-specific envelope peptides.
    Goubau P; Desmyter J; Swanson P; Reynders M; Shih J; Surmont I; Kazadi K; Lee H
    J Med Virol; 1993 Jan; 39(1):28-32. PubMed ID: 8093712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
    Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
    J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
    Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
    J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.
    Hernández M; Selles ME; Pozo Peña L; Gómez I; Melchor A
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1085-8. PubMed ID: 11027594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of two commercial human T-cell lymphotropic virus western blot (immunoblot) kits with problem specimens.
    Gallo D; Diggs JL; Hanson CV
    J Clin Microbiol; 1994 Sep; 32(9):2046-9. PubMed ID: 7814523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping.
    Zhang XQ; Yang L; Ho DD; Kuritzkes DR; Chen IS; Ching WT; Chen YM; Schooley RT
    J Infect Dis; 1992 May; 165(5):805-12. PubMed ID: 1373751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns.
    Abrams A; Akahata Y; Jacobson S
    Viruses; 2011 Aug; 3(8):1320-31. PubMed ID: 21994781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a type-specific protein that differentiates serologically between human T cell lymphotropic virus types I and II.
    Carrera-Zandomeni M; Zandomeni R; Esteban EN; Ferrer JF
    J Infect Dis; 1993 May; 167(5):1021-6. PubMed ID: 8486936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of a monoclonal antibody directed against HTLV-1 p19: use in a specific capture enzyme immunoassay.
    Ebersold A; Noraz N; Grange J; Gasmi M; Grange MP; Souche S; Mamoun R; Desgranges C
    Hybridoma; 1993 Apr; 12(2):185-95. PubMed ID: 7686136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural localization of HTLV-I gag proteins p19 and p24 by single and double immunogold labeling.
    Stransky G; Gay S
    J Histochem Cytochem; 1991 Feb; 39(2):185-91. PubMed ID: 1987262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.
    Londos-Gagliardi D; Jauvin V; Armengaut MH; Astier-Gin T; Goetz M; Huet S; Guillemain BJ
    AIDS Res Hum Retroviruses; 1999 Jul; 15(10):909-20. PubMed ID: 10408728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.